Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,695,646
-
Share change
-
-31,470
-
Total reported value
-
$23,072,000
-
Price per share
-
$8.56
-
Number of holders
-
11
-
Value change
-
-$269,384
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q4 2016
As of 31 Dec 2016,
SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,695,646 shares.
The largest 10 holders included
LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., AXA, First Eagle Investment Management, LLC, SPHERA FUNDS MANAGEMENT LTD., Granite Point Capital Management, L.P., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, DEUTSCHE BANK AG\, and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.